What is the treatment for a patient with antidromic atrioventricular reentrant tachycardia (AVRT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Antidromic AVRT

For antidromic AVRT, avoid AV nodal blocking agents (adenosine, verapamil, diltiazem) and instead use procainamide or ibutilide for hemodynamically stable patients, or immediate synchronized cardioversion for unstable patients. 1

Critical Distinction from Orthodromic AVRT

Antidromic AVRT is fundamentally different from orthodromic AVRT because the accessory pathway conducts antegradely (atria to ventricles) while the AV node conducts retrogradely, creating a wide-complex tachycardia that mimics ventricular tachycardia. 2, 3 This occurs in less than 5-10% of patients with WPW syndrome. 2

Acute Management Algorithm

For Hemodynamically Unstable Patients:

  • Immediate synchronized cardioversion is the definitive first-line treatment without attempting pharmacologic therapy. 1
  • Do not delay cardioversion for drug preparation if the patient demonstrates hypotension, altered mental status, signs of shock, acute heart failure, or ongoing chest pain. 4

For Hemodynamically Stable Patients:

  • Ibutilide or intravenous procainamide are the recommended first-line agents (Class I, Level B-R). 1
  • These agents work by prolonging the refractory period of the accessory pathway, which is the antegrade limb of the circuit in antidromic AVRT. 5
  • Synchronized cardioversion should be performed if pharmacologic therapy fails or is contraindicated. 1

Critical Contraindications

Never use AV nodal blocking agents in antidromic AVRT:

  • Adenosine, verapamil, diltiazem, and digoxin are contraindicated because they block the AV node (the retrograde limb) but do not affect the accessory pathway (the antegrade limb). 5
  • These agents may paradoxically enhance conduction down the accessory pathway, potentially increasing ventricular rate or precipitating ventricular fibrillation. 5
  • This is the same principle that applies to pre-excited atrial fibrillation—the accessory pathway must be targeted, not the AV node. 1

Distinguishing Antidromic AVRT from VT

The wide-complex tachycardia of antidromic AVRT is frequently misdiagnosed as ventricular tachycardia:

  • Antidromic AVRT presents as a regular wide-complex tachycardia with a QRS duration often >170 milliseconds due to ventricular activation via the accessory pathway. 2
  • The baseline ECG may show pre-excitation (delta waves) if the pathway conducts during sinus rhythm, helping identify WPW syndrome. 3
  • However, some accessory pathways are concealed or latent, showing no pre-excitation at baseline, making diagnosis more challenging. 3, 6
  • Adenosine can be diagnostic (terminating orthodromic AVRT or AVNRT) but should be used cautiously as it may precipitate atrial fibrillation with rapid ventricular response via the accessory pathway. 1, 7

Definitive Management

  • Catheter ablation is the treatment of choice for patients with symptomatic antidromic AVRT and should be considered after acute stabilization. 2, 3
  • Ablation success rates are high, though anteroseptal and septal pathways near the His bundle pose technical challenges and may require cryoablation rather than radiofrequency ablation to avoid AV block. 2
  • The prognostic significance of inducible antidromic AVRT during electrophysiology study remains controversial, though it may indicate higher risk in pediatric populations. 2

Common Pitfalls

  • Misdiagnosing antidromic AVRT as VT and treating with amiodarone or other agents that don't address the accessory pathway. 2, 6
  • Using AV nodal blockers (the most dangerous error), which can worsen the arrhythmia or precipitate life-threatening rhythms. 5
  • Failing to recognize pre-excited atrial fibrillation, which requires the same treatment approach as antidromic AVRT (procainamide/ibutilide or cardioversion, never AV nodal blockers). 1

Related Questions

What are the features and management of Orthodromic Atrioventricular Reentrant Tachycardia (OAVRT)?
In antidromic re‑entry tachycardia, where is the P wave located relative to the QRS complex and where is the T wave located?
What are the differences between sinus Wolff‑Parkinson‑White (WPW) and antidromic Wolff‑Parkinson‑White (WPW)?
How can pre-excitation be identified on a baseline electrocardiogram (ECG) in a patient with a history of recurrent supraventricular tachycardia (SVT)?
Are palpitations and tachycardia the same condition?
What to look for on an abdominal X-ray (abdominal radiograph) in a 2-year-old child presenting with vomiting and diarrhea?
How does Graves' disease impact psychiatric symptoms in adults, especially women, with a history of thyroid disorders or other autoimmune conditions?
Why is a patient with a history of low ferritin levels, taking Adderall (amphetamine and dextroamphetamine), and experiencing heavy menstrual bleeding, scheduled for an ablation procedure, feeling her heartbeat, particularly at night, despite having normal blood pressure readings and staying hydrated?
What is the recommended dose of famciclovir (famciclovir) for an adult patient with normal renal function and impaired renal function?
What is the treatment protocol for herpes zoster using Ganciclovir, particularly in immunocompromised patients?
What is a good protocol for adding pressors, such as norepinephrine (vaso), epinephrine (epi), and levophed (levo), in the catheterization lab for patients with acute hypotension?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.